Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
European Journal of Haematology
|
September 1, 2022
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma
Adrien Daniel, David Ghez, Camille Ravaiau, et al.
Blood Advances
|
December 6, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm
Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2019
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Timothy A Brighton, Amit Khot, Simon J Harrison, et al.
Blood
|
February 14, 2018
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
David Ghez, Anne Calleja, Caroline Protin, et al.
Leukemia & Lymphoma
|
November 29, 2017
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
Mathilde Ruggiu, Florence Oberkampf, David Ghez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines
Damien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Bulletin Du Cancer
|
January 1, 2018
[Hodgkin lymphoma: Current and future therapeutic strategies]
Anthony Turpin, Jean-Marie Michot, Emmanuelle Kempf, et al.
Plos One
|
May 30, 2008
Case-control cohort study of patients' perceptions of disability in mastocytosis
Olivier Hermine, Olivier Lortholary, Phillip S Leventhal, et al.
Hemasphere
|
June 24, 2022
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
Kamel Laribi, Alix Baugier de Materre, David Ghez, et al.
American Journal of Hematology
|
April 5, 2019
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group
Anne Quinquenel, Sophie Godet, Caroline Dartigeas, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
European Journal of Haematology
|
September 1, 2022
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma
Adrien Daniel, David Ghez, Camille Ravaiau, et al.
Blood Advances
|
December 6, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm
Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2019
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Timothy A Brighton, Amit Khot, Simon J Harrison, et al.
Blood
|
February 14, 2018
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
David Ghez, Anne Calleja, Caroline Protin, et al.
Leukemia & Lymphoma
|
November 29, 2017
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
Mathilde Ruggiu, Florence Oberkampf, David Ghez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines
Damien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Bulletin Du Cancer
|
January 1, 2018
[Hodgkin lymphoma: Current and future therapeutic strategies]
Anthony Turpin, Jean-Marie Michot, Emmanuelle Kempf, et al.
Plos One
|
May 30, 2008
Case-control cohort study of patients' perceptions of disability in mastocytosis
Olivier Hermine, Olivier Lortholary, Phillip S Leventhal, et al.
Hemasphere
|
June 24, 2022
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
Kamel Laribi, Alix Baugier de Materre, David Ghez, et al.
American Journal of Hematology
|
April 5, 2019
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group
Anne Quinquenel, Sophie Godet, Caroline Dartigeas, et al.
Page
of 8